A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease

Clinical trial NCT06885567 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06885567
Sponsor: BeyondBio Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Alzheimer' Disease

Start date: 2025-07-01
Primary completion: 2028-07-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.